ASTH Astrana Health Inc.

  1. Stocks
  2. Healthcare
  3. NASDAQ: ASTH

Price (delayed)

$37.01

Market cap

$2.05B

P/E Ratio

28.47

Dividend/share

N/A

EPS

$1.3

Enterprise value

$2.08B

apollo medical holdings, inc., a physician-centric technology-powered healthcare management company, provides medical care services. the company, leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based ...

Highlights
The EPS has grown by 38% since the previous quarter and by 30% year-on-year
Astrana Health's net income has increased by 36% QoQ and by 34% YoY
The debt has increased by 40% year-on-year and by 36% since the previous quarter
Astrana Health's quick ratio has decreased by 29% YoY and by 13% from the previous quarter
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://apollomed.net
Peers: INNV NHC

Key stats

What are the main financial stats of ASTH
Market
Shares outstanding
55.42M
Market cap
$2.05B
Enterprise value
$2.08B
Valuations
Price to earnings (P/E)
28.47
Price to book (P/B)
3.51
Price to sales (P/S)
1.56
EV/EBIT
19.1
EV/EBITDA
15.54
EV/Sales
1.5
Earnings
Revenue
$1.39B
EBIT
$108.81M
EBITDA
$133.74M
Free cash flow
$39.7M
Per share
EPS
$1.3
Free cash flow per share
$0.68
Book value per share
$10.54
Revenue per share
$23.79
TBVPS
$10
Balance sheet
Total assets
$933.36M
Total liabilities
$522.59M
Debt
$321.01M
Equity
$614.22M
Working capital
$242.83M
Liquidity
Debt to equity
0.52
Current ratio
2.11
Quick ratio
1.98
Net debt/EBITDA
0.2
Margins
EBITDA margin
9.6%
Gross margin
15.5%
Net margin
4.4%
Operating margin
6.1%
Efficiency
Return on assets
6%
Return on equity
10.5%
Return on invested capital
25.1%
Return on capital employed
15.2%
Return on sales
7.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ASTH stock price

How has the Astrana Health stock price performed over time
Intraday
-1.25%
1 week
-1.07%
1 month
-6.71%
1 year
-1.41%
YTD
-3.37%
QTD
-11.86%

Financial performance

How have Astrana Health's revenue and profit performed over time
Revenue
$1.39B
Gross profit
$214.96M
Operating income
$84.61M
Net income
$60.72M
Gross margin
15.5%
Net margin
4.4%
Astrana Health's net income has increased by 36% QoQ and by 34% YoY
The company's operating margin fell by 33% YoY and by 20% QoQ
The net margin has increased by 29% since the previous quarter and by 13% year-on-year
The revenue is up by 21% year-on-year and by 4.4% since the previous quarter

Growth

What is Astrana Health's growth rate over time

Valuation

What is Astrana Health stock price valuation
ASTH P/E details
P/E
28.47
P/B
3.51
P/S
1.56
EV/EBIT
19.1
EV/EBITDA
15.54
EV/Sales
1.5
The EPS has grown by 38% since the previous quarter and by 30% year-on-year
The price to earnings (P/E) is 30% lower than the 5-year quarterly average of 40.6 and 13% lower than the last 4 quarters average of 32.9
ASTH's price to book (P/B) is 25% lower than its 5-year quarterly average of 4.7 but 3.2% higher than its last 4 quarters average of 3.4
Astrana Health's equity has increased by 13% YoY and by 3.5% from the previous quarter
ASTH's P/S is 29% below its 5-year quarterly average of 2.2 but 4% above its last 4 quarters average of 1.5
The revenue is up by 21% year-on-year and by 4.4% since the previous quarter

Efficiency

How efficient is Astrana Health business performance
Astrana Health's return on assets has increased by 36% QoQ and by 25% YoY
Astrana Health's return on equity has increased by 33% QoQ and by 17% YoY
The company's return on invested capital rose by 15% YoY and by 10% QoQ
The return on sales has declined by 4.9% year-on-year but it has grown by 4% since the previous quarter

Dividends

What is ASTH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ASTH.

Financial health

How did Astrana Health financials performed over time
The total assets is 79% more than the total liabilities
Astrana Health's quick ratio has decreased by 29% YoY and by 13% from the previous quarter
The company's total liabilities rose by 28% YoY and by 14% QoQ
The debt is 48% smaller than the equity
The debt has increased by 40% year-on-year and by 36% since the previous quarter
The company's debt to equity rose by 30% QoQ and by 24% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.